别名 Blennorrhea, Inclusion、Blennorrheas, Inclusion、CONJUNCTIVITIS, CHLAMYDIA + [41] |
简介 An infection of the eyes characterized by the presence in conjunctival epithelial cells of inclusion bodies indistinguishable from those of trachoma. It is acquired by infants during birth and by adults from swimming pools. The etiological agent is CHLAMYDIA TRACHOMATIS whose natural habitat appears to be the genito-urinary tract. Inclusion conjunctivitis is a less severe disease than trachoma and usually clears up spontaneously. |
作用机制 30S subunit抑制剂 |
原研机构 |
最高研发阶段批准上市 |
首次获批国家/地区 美国 |
首次获批日期1967-12-05 |
靶点- |
作用机制 干细胞替代物 |
非在研适应症- |
最高研发阶段临床1/2期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
靶点 |
作用机制 DHPS抑制剂 |
在研机构- |
在研适应症- |
最高研发阶段撤市 |
首次获批国家/地区 美国 |
首次获批日期1953-12-04 |
开始日期2022-11-11 |
开始日期2011-07-20 |
开始日期2007-09-01 |